Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. BHCHX: which is better?

Bottom line

PRHSX vs BHCHX: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and BHCHX (Baron Health Care Fund) share a meaningful slice of their top holdings — about 50% by weight.

But PRHSX is far broader, holding 279 positions to 43 for BHCHX, so beyond the top names it adds exposure BHCHX doesn't have.

PRHSX is cheaper at 0.83% vs 0.85% — a difference of $2.00 a year per $10,000 invested.

Over five years, PRHSX returned +4.2% a year vs +2.8% for BHCHX.

Updated Nov 19, 2026

PRHSX vs BHCHX side by side

PRHSXBHCHX
TypeMutual fundMutual fund
Fund familyT. Rowe PriceBaron Select
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%0.85%
Annual cost per $10k$83$85
10-yr cost on $10k (prospectus)$1,025$1,049
Max front load——
12b-1 fee—0%
1-yr return+17.7%+10.3%
5-yr return (annualized)+4.2%+2.8%
10-yr return (annualized)+9.1%—
Best quarter+23.5%—
Worst quarter−15.8%—
Net assets (fund)$11.9B$114.1M
Number of holdings27943
Portfolio turnover62%74%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

13 of PRHSX's top 25 holdings also appear in BHCHX's top 25.

Shared top holdings
HoldingPRHSXBHCHX
Eli Lilly & Co14.28%13.66%
Johnson & Johnson6.63%5.56%
Unitedhealth Group Inc5.99%3.28%
Merck & Co. Inc.4.01%2.48%
Gilead Sciences Inc2.82%1.99%
Thermo Fisher Scientific Inc2.52%3.91%
Vertex Pharmaceuticals Inc2.28%2.61%
Intuitive Surgical Inc1.87%1.74%
Elevance Health Inc1.53%1.69%
Natera Inc1.44%1.93%
Guardant Health Inc1.23%2.17%
Kymera Therapeutics Inc0.89%2.01%
Protagonist Therapeutics Inc0.85%1.72%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

BHCHX top 10

  1. Eli Lilly & Co — 13.66%
  2. Mettler-Toledo International Inc — 5.60%
  3. Johnson & Johnson — 5.56%
  4. Argenx SE — 4.23%
  5. Thermo Fisher Scientific Inc — 3.91%
  6. Roivant Sciences Ltd — 3.88%
  7. Teva Pharmaceutical Industries Ltd — 3.86%
  8. Welltower Inc — 3.38%
  9. UnitedHealth Group Inc — 3.28%
  10. RadNet Inc — 3.24%

FAQ

What is the difference between PRHSX and BHCHX?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and BHCHX (Baron Health Care Fund) share a meaningful slice of their top holdings — about 50% by weight. But PRHSX is far broader, holding 279 positions to 43 for BHCHX, so beyond the top names it adds exposure BHCHX doesn't have.
Which is cheaper, PRHSX or BHCHX?
PRHSX has the lower expense ratio (0.83%).
Should I own both PRHSX and BHCHX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.